Connect
MJA

Volume 165 Issue 6

16 September 1996

Editorials

  • From knowledge to action: improving drug prescribing Robert F W Moulds (MJA 1996; 165: 299)
  • Hepatitis B in Australia: on course for universal vaccination Paul N Goldwater (MJA 1996; 165: 300)
  • The new genetics: legal and ethical implications for medicine Loane Skene, Max Charlesworth (MJA 1996; 165: 301)
  • Haematopoietic growth factors and chemotherapy: new horizons Kerrie Clarke, Russell Basser, Richard M Fox (MJA 1996; 165: 303)

Research

  • Benzodiazepine prescribing in a Sydney teaching hospital Jan B Howes, Jillian Ryan, Gregory Fairbrother, Kevin O'Neill, Laurence G Howes Abstract - Article (MJA 1996; 165: 305)
  • Premature mortality in Aboriginal adults in the Northern Territory, 1979-1991 Joan Cunningham, John R Condon (MJA 1996; 165: 309)
  • Changing epidemiology of Ross River virus disease in South Australia Suzanne M Selden, A Scott Cameron (MJA 1996; 165: 313)

Notable Cases

  • Visceral angioedema related to treatment with an ACE inhibitor Raymond J Mullins, Timothy M Shanahan, Ronald T Dobson (MJA 1996; 165: 319)

Public Health

  • The incidence of hepatitis B infection in Australia: an epidemiological review John M Kaldor, Aileen J Plant, Sandy C Thompson, Helen Longbottom, Jill Rowbottom (MJA 1996; 165: 322)

Viewpoint

  • Confidentiality and the AMA's new code of ethics: an imprudent formulation? Helga Kuhse (MJA 1996; 165: 327)

MJA Practice Essentials - Rheumatology

  • A template for diagnosis and management of musculoskeletal diseases Peter M Brooks (MJA 1996; 165: 331)
  • Osteoporosis Philip N Sambrook (MJA 1996; 165: 332)

Medicine and the Community